Practical Considerations for Detecting NTRK Gene Fusions

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD; Arturo Loaiza-Bonilla, MD, MSEd, FACP

Video Categories: NTRK Gene Fusions

Dr Ezra Cohen of UC San Diego, La Jolla, CA; Dr Mary Fidler of Rush University Medical Center, Chicago, IL; and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, review molecular methodologies and factors to consider in the identification of TRK fusion–positive tumors.

October 16, 2015

A Look Into Anti-PD-1 and Anti-PD-L1 Therapies

Dr. Sanjiv Agarwala analyzes anti-PD-1 and anti-PD-L1 therapies in terms what they do and their unique toxicities and response patterns.

September 20, 2013

Absorbing the Cost of Personalized Medicine

Matthew Palmgren discusses the benefits of personalized medicines